Clinical Trial Update: Preterm Infant Inhaled Albuterol Dosing [Phase 4]

View source ↗

Summary

Phase 4 trial update on inhaled albuterol dosing in preterm infants with bronchopulmonary dysplasia and very low birth weight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Very Low Birth Weight

Drugs mentioned

• Albuterol (albuterol)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Bronchopulmonary Dysplasia, Very Low Birth Weight | Phase 4 | Status: COMPLETED | Results posted: 2019-05-23